Alaska Permanent Fund’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Alaska Permanent Fund’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,418	Closed	-$2.11M	–	456
2025 Q1	$2.11M	Hold	25,418	–	–	0.03%	266
2024 Q4	$2.29M	Sell	25,418 -78,539	-76%	-$7.61M	0.03%	268
2024 Q3	$10.3M	Hold	103,957	–	–	0.15%	71
2024 Q2	$10.3M	Sell	103,957 -766,347	-88%	-$68.7M	0.15%	71
2024 Q1	$82.6M	Sell	870,304 -287,205	-25%	-$26.7M	1.22%	19
2023 Q4	$103M	Hold	1,157,509	–	–	1.7%	18
2023 Q3	$84.5M	Sell	1,157,509 -189,889	-14%	-$15.2M	1.59%	18
2023 Q2	$112M	Buy	+1,347,398	New	+$113M	2.2%	14
2022 Q4	$151M	Buy	+1,823,265	New	+$148M	2.47%	12

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $134M AUM 21.11% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alaska Permanent Fund's XBI Position: Q2 2025 in Review

Alaska Permanent Fund sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 25,418 shares — an estimated $2.11M sold.

Alaska Permanent Fund first reported a position in XBI in Q4 2022 and held it in 9 quarters. The position peaked at $151M in Q4 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Alaska Permanent Fund reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Alaska Permanent Fund sold 25,418 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $2.11M.
Alaska Permanent Fund first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 9 quarters.
Alaska Permanent Fund's State Street SPDR S&P Biotech ETF position peaked at $151M in Q4 2022.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.